Stock Price
165.86
Daily Change
-0.89 -0.53%
Monthly
12.82%
Yearly
61.37%
Q3 Forecast
165.37

Ligand Pharmaceuticals reported $43.03 in PE Price to Earnings for its fiscal quarter ending in March of 2025.




Pe Change Date
Amgen USD 12.51 28.7 Jun/2025
Arrowhead Research USD 436.79 383.28 Jun/2020
Baxter International USD 21.56 95.08 Jun/2025
Bristol-Myers Squibb USD 17.27 3.22 Jun/2025
Eli Lilly USD 37 7.55 Jun/2025
Gilead Sciences USD 15.39 279.48 Jun/2025
GlaxoSmithKline GBP 18.27 5.23 Jun/2025
Glaxosmithkline GBP 18.39 3.81 Jun/2025
Ionis Pharmaceuticals USD 396.15 79.28 Sep/2022
Ligand Pharmaceuticals USD 43.03 4.09 Mar/2025
Merck USD 8.58 4.74 Jun/2025
Pacira USD 23.09 5.46 Jun/2025
Pfizer USD 9.12 8.86 Jun/2025
Veracyte USD 42.66 21.92 Jun/2025